Clinical Trial Update: Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Linezolid for catheter-related Gram-positive bloodstream infections in hemodialysis patients was terminated, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Catheter-related Bloodstream Infection

Drugs mentioned

• ZYVOX (LINEZOLID)

Snippet

Sponsor: Pfizer | Conditions: Bacteremia, Gram-Positive Bacterial Infections | Phase 3 | Status: TERMINATED | Results posted: 2012-08-07